Tff Pharmaceuticals Inc
TFFP
Get informed when a big investor buys or sells
+ FollowMarket Cap$288.8K
Close$
$5.60
8520.5% upside
Current Fair Value
8520.5% upsideUndervalued by 8520.5% based on the discounted cash flow analysis.
Share Statistics
| Market cap | $288,798.00 |
|---|---|
| Enterprise Value | $-2,014,603.00 |
| Dividend Yield | $- (-) |
| Earnings per Share | $-11.85 |
| Beta | 1.32 |
| Outstanding Shares | 4,372,458 |
Return
| Return on Equity | -590.38% |
|---|---|
| Return on Assets | -261.68% |
| Return on Invested Capital | -627.05% |
Valuation & Multiples
| P/E Ratio | -0.01 |
|---|---|
| PEG | 0.03 |
| Price to Sales | - |
| Price to Book Ratio | - |
| Enterprise Value to Revenue | -1.13 |
| Enterprise Value to EBIT | 0.1 |
| Enterprise Value to Net Income | 0 |
| Total Debt to Enterprise | -0.15 |
| Debt to Equity | 0.1 |
Revenue Sources
No data
Insider Trades
Institutional Sentiment (Put/Call)
No data available for the latest quarter.
Institutional Ownership
No data available for the latest quarter.
ESG Score
No data
About Tff Pharmaceuticals Inc
4 employeesTFF Pharmaceuticals, Inc. is a clinical-stage biopharmaceutical company focused on developing and commercializing innovative drug products based on its patented Thin Film Freezing, or TFF, technology platform. Early testing confirms that...